KOTRA (0002.KL) Financials
0002.KL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 325.8 million | 51.1 million |
| 2023-09-30 | 343.0 million | 57.0 million |
| 2023-06-30 | 330.3 million | 59.2 million |
| 2023-03-31 | 308.2 million | 50.4 million |
0002.KL Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 14.1 million | ? |
| 2023-09-30 | 9.0 million | 44000 |
| 2023-06-30 | 10.1 million | ? |
| 2023-03-31 | 832000 | ? |
0002.KL Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 11.9 million |
| 2023-09-30 | 13.9 million |
| 2023-06-30 | 13.5 million |
| 2023-03-31 | 17.7 million |
0002.KL Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 91.2 million | - | 568000 |
| 2023-09-30 | 100.4 million | - | 808000 |
| 2023-06-30 | 89.0 million | 82000 | 1.0 million |
| 2023-03-31 | 76.1 million | 82000 | 326000 |
0002.KL Shares Outstanding
0002.KL Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 5.3 million | - | - | - |
| 2023-09-30 | 8.6 million | - | - | - |
| 2023-06-30 | 5.5 million | - | - | - |
| 2023-03-31 | 9.4 million | - | - | - |
0002.KL Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 57.5 million | 45.4 million |
| 2023-09-30 | 53.3 million | 41.4 million |
| 2023-06-30 | 55.8 million | 49.9 million |
| 2023-03-31 | 59.4 million | 42.7 million |
0002.KL
Price: MYR4.68
Dividend Yield: 5.27%
Forward Dividend Yield: 5.34%
Payout Ratio: 65.79%
Dividend Per Share: 0.25 MYR
Earnings Per Share: 0.38 MYR
P/E Ratio: 12.50
Exchange: KLS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 704.5 million
Average Dividend Frequency: 2
Years Paying Dividends: 8
DGR3: 30.00%
DGR5: 30.00%